The Role of Hyaluronan And Inter-Alpha-Trypsin Inhibitor in Tissue Injury

透明质酸和间α-胰蛋白酶抑制剂在组​​织损伤中的作用

基本信息

项目摘要

Environmental tissue injury affects extracellular matrix (ECM) both directly and indirectly: environmental stimuli may directly modify the composition of matrix, e.g. inhaled ozone exposure leads to breakdown of high molecular weight hyaluronan (an abundant ECM component) to low-molecular weight fragments; indirectly, environmental injury induces de-novo production of ECM components or translocation of ECM molecules into the interstitial space, e.g. the serum protein inter-alpha-trypsin inhibitor (IaI) extravasates to the interstitium in fibrotic lung injury. Our research focuses on these two abundant yet understudied molecules, and evaluates how they affect the response to tissue injury. Concretely, our research touches on 2 separate but inter-related subjects: 1) To investigate the role of IaI and hyaluronan in airway hyperreactivity after environmental exposures; 2) To investigate the role of IaI and hyaluronan in tissue healing after injury In the first Aim, we were able to show that low-molecular weight hyaluronan is released in the lung airways after ozone exposure in the murine model. Furthermore, we showed that hyaluronan binding through IaI and the cell receptor CD44 is necessary for the mediation of airway hyperreactivity. CD44 is acting in co-receptor fashion with the innate immune receptor TLR4. Finally, hyaluronan binding blockade, IaI blockade, or high molecular weight hyaluronan can be used therapeutically to ameliorate airway hyperreactivity in the mouse model. We have identified a number of agents that can effectively inhibit airway hyperresponsiveness in various mouse models of asthma. A patent application was granted recently. Expansion into clinical studies is actively pursued. In the second Aim, we investigate the role of IaI and hyaluronan in lung injury. We have showed that IaI and hyaluronan are necessary for angiogenesis after lung injury in the mouse model, and that IaI and hyaluronan colocalize in the fibrotic areas of human patients with pulmonary fibrosis, particularly around areas of neovascularization. Furthermore, we showed that IaI serum levels in pulmonary fibrosis patients are higher than in control subjects and correlate inversely with gas exchange capacity in these subjects. Furthermore we identified novel IaI interactions, namely with the ECM molecules complement C3, C4, vitronectin and tenascin C. These interactions appear to protect against lung inflammation as well as support epithelial wound healing. Other interacting agents have been also identified. IaI therefore emerges as a multipotent "tissue-healing" factor with potential therapeutic applications. In addition, recently we expanded our research to address the role of HA and IaI in COVID-19 lung injury This project involves research on human coronavirus, novel coronavirus, COVID-19, Severe Acute Respiratory Syndrome coronavirus disease, SARS coronavirus, SARS-coronavirus-2, SARS-cov-2, SARS-cov2, SARS-related coronavirus 2, Severe acute respiratory syndrome coronavirus 2, SARS-Associated Coronavirus, SARS-cov, or SARS-Related Coronavirus.
环境组织损伤可直接或间接影响细胞外基质(ECM):环境刺激可直接改变基质的组成,如吸入臭氧暴露可导致高分子量透明质酸(ECM的丰富成分)分解为低分子量碎片;间接地,环境损伤诱导ECM成分的重新生成或ECM分子转移到间质空间,例如,血清蛋白α -胰蛋白酶间质抑制剂(IaI)在纤维化肺损伤中向间质外渗。我们的研究重点是这两种丰富但尚未被充分研究的分子,并评估它们如何影响组织损伤的反应。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Stavros Garantziotis其他文献

Stavros Garantziotis的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Stavros Garantziotis', 18)}}的其他基金

Program in Clinical Research, Clinical Support Services and Clinical Training
临床研究、临床支持服务和临床培训项目
  • 批准号:
    9550665
  • 财政年份:
  • 资助金额:
    $ 175.38万
  • 项目类别:
The Role of Hyaluronan And Inter-Alpha-Trypsin Inhibitor in Tissue Injury
透明质酸和间α-胰蛋白酶抑制剂在组​​织损伤中的作用
  • 批准号:
    7734582
  • 财政年份:
  • 资助金额:
    $ 175.38万
  • 项目类别:
The Role of Hyaluronan And Inter-Alpha-Trypsin Inhibitor in Tissue Injury
透明质酸和间α-胰蛋白酶抑制剂在组​​织损伤中的作用
  • 批准号:
    9550141
  • 财政年份:
  • 资助金额:
    $ 175.38万
  • 项目类别:
The Role of Hyaluronan And Inter-Alpha-Trypsin Inhibitor in Tissue Injury
透明质酸和间α-胰蛋白酶抑制剂在组​​织损伤中的作用
  • 批准号:
    8553793
  • 财政年份:
  • 资助金额:
    $ 175.38万
  • 项目类别:
The Role of Hyaluronan And Inter-Alpha-Trypsin Inhibitor in Tissue Injury
透明质酸和间α-胰蛋白酶抑制剂在组​​织损伤中的作用
  • 批准号:
    10928601
  • 财政年份:
  • 资助金额:
    $ 175.38万
  • 项目类别:
The Role of Hyaluronan And Inter-Alpha-Trypsin Inhibitor in Tissue Injury
透明质酸和间α-胰蛋白酶抑制剂在组​​织损伤中的作用
  • 批准号:
    8149113
  • 财政年份:
  • 资助金额:
    $ 175.38万
  • 项目类别:
The Role of Hyaluronan And Inter-Alpha-Trypsin Inhibitor in Tissue Injury
透明质酸和间α-胰蛋白酶抑制剂在组​​织损伤中的作用
  • 批准号:
    8336649
  • 财政年份:
  • 资助金额:
    $ 175.38万
  • 项目类别:
The Role of Hyaluronan And Inter-Alpha-Trypsin Inhibitor in Tissue Injury
透明质酸和间α-胰蛋白酶抑制剂在组​​织损伤中的作用
  • 批准号:
    8929799
  • 财政年份:
  • 资助金额:
    $ 175.38万
  • 项目类别:
The Role of Hyaluronan And Inter-Alpha-Trypsin Inhibitor in Tissue Injury
透明质酸和间α-胰蛋白酶抑制剂在组​​织损伤中的作用
  • 批准号:
    10000732
  • 财政年份:
  • 资助金额:
    $ 175.38万
  • 项目类别:
The Role of Hyaluronan And Inter-Alpha-Trypsin Inhibitor in Tissue Injury
透明质酸和间α-胰蛋白酶抑制剂在组​​织损伤中的作用
  • 批准号:
    7968252
  • 财政年份:
  • 资助金额:
    $ 175.38万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 175.38万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 175.38万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 175.38万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 175.38万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 175.38万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 175.38万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 175.38万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 175.38万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 175.38万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 175.38万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了